Domov › Mikrocitni rak pljuč › Ohio
Klinične študije za Mikrocitni rak pljuč v Ohio
28 študij za Mikrocitni rak pljuč išče udeležence na lokacijah v Ohio.
Mesta v Ohio
Uradno besedilo študije (angleško)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- University Hospitals Cleveland Medical Center /ID# 277556, Cleveland
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07155174Prospective Multiomic Analysis in Small-Cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07795411The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07226999A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Canton
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07099898DESTINY-PANTUMOUR04
- Research Site, Canton
- Research Site, Maumee
Vključevanje udeležencevOpazovalna študija
Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07365241Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07278479A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
- University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07325136A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Cleveland Clinic - Akron General Medical Center, Akron
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic - Fairview Hospital Molly Pavilion, Cleveland
- in še 2
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07218146A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Oncology Hematology Care, Cincinnati
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06646276Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cleveland Clinic - Akron General Hematology & Oncology, Akron
- Cleveland Clinic Mercy Hospital Cancer Center, Canton
- The Christ Hospital Cancer Center, Cincinnati
- in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Ohio State Univerity, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07057791A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06892548A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Oncology Hematology Care Clinical Trials, Cincinnati
- University Hospital - Cleveland Medical Center, Cleveland
- Zangmeister Cancer Center, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06095505A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Cleveland Clinic Mercy Hospital, Canton
- Oncology/Hematology Care Clinical Trials, Llc, Cincinnati
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06203210Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT07423585A Study of LY4175408 in Participants With Advanced Cancer
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- TriHealth Cancer Institute, Cincinnati
- Ohio State University, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT05257551Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Cleveland Clinic, Cleveland
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 8. maj 2026 · NCT05363280Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 8. apr. 2026 · NCT04919382Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Aultman Health Foundation, Canton
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- in še 5
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT06769126Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Cleveland Clinic, Cleveland
- Taylor Cancer Research Center, Maumee
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT07030257VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Taylor Cancer Research Center (site 204), Maumee
Vključevanje udeležencevFaza 1/2
Starost 18–80 · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT03556228A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 138, Canton
- Research Site 113, Cincinnati
- Research Site 131, Dayton
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 21. nov. 2025 · NCT05914116A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Case Comprehensive Cancer Center, Cleveland
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2025 · NCT06805825A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
- Zelgen Site 101, Canton
- Zelgen Site 104, Cleveland
Vključevanje udeležencevFaza 1
Starost 18–75 · Vsi spoli · Posodobljeno 6. avg. 2025 · NCT06592638Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.